Bioverge, Inc.

11/03/2021

In a deal just announced this week, Bioverge portfolio company Volumetric has entered into an agreement for acquisition by 3D Systems (NASDAQ: DDD).

We could not be more thrilled for the Volumetric team and for participating Bioverge investors on the successful exit!

​​We first met Volumetric co-founders Jordan and Bagrat...

https://bioverge.com/blog/volumetric-to-be-acquired-by-3d-systems

10/25/2021

Over 15,000 people are registered on the waiting list for a liver transplant, but an additional ~200,000 people have later stage disease and are not currently on the waiting list. While only 3% of these individuals are able to receive a transplant, Hepatx's revolutionary solution has the potential to be an effective cell therapy platform for liver disease.

10/15/2021

BioRosa has developed an AI-enabled blood test for the early diagnosis of Autism.

Autism Spectrum Disorder (ASD) is the largest pediatric neurodevelopmental disorder in the world and affects an estimated 1 in 54 children in the U.S. and 3% of children worldwide. With early diagnosis and treatment, health-related costs of Autism could be dramatically decreased.

10/06/2021

Pleased to share our CEO Neil Littman's latest Forbes Finance Council article, "Myth-busting in Equity Crowdfunding".

What do you think are the top myths (or obstacles) to companies pursing a offering?

With these new regulatory changes and the strong increase recently in equity crowdfunding activity, now’s a perfect time to dispel some myths about the sector.

09/15/2021

On this week's podcast, Lindy Morris Fishburne, Managing Partner of Breakout Ventures, sits down with Neil Littman to discuss investing in seed-and early-stage bioscience companies, and what she learned working with entrepreneurial scientists at Breakout Labs.

Available on SoundCloud: https://hubs.la/H0XnMsW0

Available on iTunes: https://hubs.la/H0XnGMM0

Lindy Fishburne, managing partner of Breakout Ventures, sits down with Neil to discuss investing in seed- and early-stage bioscience companies, and what she learned working with entrepreneurial scient

09/14/2021

Did you know that for a limited time we're offering our supporters an ownership stake in our growth?

If you believe in what we’re building and want to come along with us, we’d love for you to join our mission and help bring science fiction to life!

Learn more on our offering page via Netcapital here: https://hubs.la/H0XczqX0

08/18/2021

On the latest episode of the Bioverge Podcast, Neil Littman sits down with Eric Topol, MD, Founder and Director of the Scripps Research Translational Institute, to discuss the COVID-19 delta variant, why it's such a formidable adversary, and what steps need to be taken to combat the ongoing pandemic.

Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need

08/11/2021

The capabilities of regenerative medicine are growing at a staggering rate. Fueled by an influx of biotechnology talent and investment capital, imagined feats like lab-grown human organs are now within reach and promise to impact the lives of countless patients and families over the next decade. With so much innovation at the forefront of medicine, it is exciting to wonder where regenerative medicine will take us next. Swipe to learn more —>

07/02/2021

On the latest podcast, Juan Scarlett, MD of One Valley Ventures, discusses their efforts to democratize and his approach investing in early-stage

Juan Scarlett, managing director of OneValley Ventures, sits down with Neil to discusses OneValley's efforts to democratize entrepreneurship and his approach investing in pre-seed and seed funding rou

06/24/2021

What an exciting way to end the week! We have reached $200K in investments for Bioverge on Netcapital!

We are proud to reach this milestone and thank each and every one of you for your participation in our raise.

Join our community of investors today at the link below so you can help make a difference in the lives of people across the world! 👇

https://netcapital.com/companies/bioverge

06/22/2021

Storytelling connects us, helps us make sense of the world, communicates our values and beliefs, and sparks conversations.

Stories connect us to our communities.

Today, our Co-Founder Neil Littman shares with you his personal story that inspired him to start Bioverge. Click to listen 🎧 👉 https://www.youtube.com/watch?v=Jbaf6hDks_A

Share your story with us 👇

Join Bioverge’s Netcapital community at https://netcapital.com/companies/bioverge?utm_source=facebook&utm_medium=captions&utm_campaign=dna

Fireside Chat w Bioverge CEO Neil Littman

06/18/2021

Yes! 🙌

Our Co-Founder, Neil Littman, started his career in healthcare investment banking and had the opportunity to work on both public and private financings, including IPOs!

Neil's prior experience makes him uniquely positioned to guide Bioverge to success!

Questions about our investment opportunity? Leave them on Netcapital https://netcapital.com/companies/bioverge/ask-a-question! Neil will get back to you shortly!